AEON BIOPHARMA, INC. Shares of Class A Common Stock ($0.0001 par value per share) SALES AGREEMENTSales Agreement • August 15th, 2024 • AEON Biopharma, Inc. • Pharmaceutical preparations • New York
On the date hereof, AEON Biopharma, Inc., a Delaware corporation (the “Company”), has filed or will file with the Securities and Exchange Commission (the “Commission”) a shelf registration statement on Form S-3 that contains a base prospectus as well as a sales agreement prospectus covering the offering, issuance and sale by the Company of shares of the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”), having an aggregate offering price of up to $50,000,000. The parties agree to be legally bound by the terms of this Agreement effective immediately upon such registration statement being declared effective by the Commission.
